Overview

It’s a known fact that drug manufacturers will have to relentlessly work on vaccine development and emergency products’ manufacturing to control the health crisis like COVID-19. In such scenarios, what if the manufacturers or regulators have no option for on-site audits? What options do they have to perform audit of vendors located in different geographies across the globe? The only option is to move from a traditional audit to remote audit or virtual audit. Unquestionably, remote/virtual audits are the future for conducting audits of low-risk processes that consist of documents, forms and records that can be reviewed from a desktop.

As a proven Regulatory partner for compliance practices, Freyr emphasizes to remain complaint with vendor audits especially during emergency health crisis like COVID 19. To ensure a smooth transition from on-site physical audit to remote/virtual audit during the current pandemic, Freyr offers remote audit and SOP review/writing services based on unique 3-stage risk-based approach.

Remote Audit - 3-Stage Risk-based Approach

Freyr Team - Facts

With a global team of auditors who has audit practicing experience in various GxPs specialization (Specialists in Auditing) and with a combined experience of 144+ years, the Freyr team is set to cater to all types of multi-site complex audit programs up to 360 remote audits per year.

Skillset and Global Footprint